Research Webinars, • 8/6/24 An Approach to Screening Drugs for Preventing Disease Progression in Patients with RUNX1-FPD Previous Intro to PCOR - Defining it for the RUNX1-FPD Community Next Introduction to the RUNX1-FPD Sirolimus Pilot Study (6.24.24) You Might Also Like Neoplasias Hematológicas Hereditarias: No Tan Poco Frecuentes (September 2024) The Cryan Family Part 2: April 2025 Sirolimus Study Update Patient Participants Perspectives and Q&A Part 1: April 2025 Low-Dose Sirolimus Study Overview with Dr. Courtney DiNardo Latest Research Findings From the Ongoing NIH RUNX1 Natural History Study
Research Webinars, • 8/6/24 An Approach to Screening Drugs for Preventing Disease Progression in Patients with RUNX1-FPD Previous Intro to PCOR - Defining it for the RUNX1-FPD Community Next Introduction to the RUNX1-FPD Sirolimus Pilot Study (6.24.24) You Might Also Like Neoplasias Hematológicas Hereditarias: No Tan Poco Frecuentes (September 2024) The Cryan Family Part 2: April 2025 Sirolimus Study Update Patient Participants Perspectives and Q&A Part 1: April 2025 Low-Dose Sirolimus Study Overview with Dr. Courtney DiNardo Latest Research Findings From the Ongoing NIH RUNX1 Natural History Study
